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Abstract. We used functional photoacoustic microscopy to
image diabetes-induced damage to the microvasculature.
To produce an animal model for Type 1 diabetes, we
used streptozotocin (STZ), which is particularly toxic to
the insulin-producing beta cells of the pancreas in mam-
mals. A set number of ND4 Swiss Webster mice received
intraperitoneal injections of STZ for five consecutive days
at 50mg∕kg. Most mice developed a significant rise in
blood glucose level (∼400mg∕dL) within three weeks of
the first injection. Changes in vasculature and hemody-
namics were monitored for six weeks. The mouse ear
was imaged with an optical-resolution photoacoustic micro-
scope at a main blood vessel branch from the root of the ear.
There are noticeable and measurable changes associated
with the disease, including decreased vessel diameter and
possible occlusion due to vessel damage and polyurea.
We also observed an increase in the blood flow speed in
the vein and a decrease in the artery, which could be
due to compensation for the dehydration and vessel diam-
eter changes. Functional and metabolic parameters such as
hemoglobin oxygen saturation, oxygen extraction fraction,
and oxygen consumption rate were also measured, but
showed no significant change. © 2012 Society of Photo-Optical
Instrumentation Engineers (SPIE). [DOI: 10.1117/1.JBO.17.6.060502]
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Photoacoustic tomography (PAT) is an emerging technology that
generates high resolution, three-dimensional (3-D) images of the
distribution of light-absorbing molecules, utilizing light-induced
ultrasonic waves produced through the photoacoustic effect.1
When imaging biological tissue, PAT techniques are sensitive
primarily to optical absorbers, such as melanin, oxy-, and deoxy-
hemoglobin.2,3 The sensitivity to hemoglobin in blood has
yielded a new tool for many studies, including imaging the recov-
ery of vessels after injury, and monitoring new vessel growth.4
The difference in color between arteries and veins results from
the binding of oxygen to hemoglobin, changing the light absorp-
tion spectrum of the molecule. PAT can exploit this difference in
the absorption to reveal functional information such as oxygen
saturation (sO2). It has been shown that a spectral measurement
of blood vessels using photoacoustic microscopy can yield a
vessel-by-vessel map of the oxygen saturation in tissue.5 PAT
is also capable of measuring the flow of blood in vessels, and
the oxygen consumption rate in these tissues.6
Diabetes, characterized by excess glucose in the blood, is
a risk factor for increasing retinopathy, renal failure, and
cardiovascular disease.7 According to the American Diabetes
Association, in 2011 there were 25.8 million children and adults
with diabetes living in the United States, with 1.9 million new
cases diagnosed annually in people aged twenty years and older.
Optical-resolution photoacoustic microscopy (OR-PAM),8 one
system implementation of PATwhose lateral resolution is deter-
mined by the optical focus, can measure diabetic vasculature
and assist to better understand the physiologic changes induced
by diabetes.
The OR-PAM system used in this study is shown in Fig. 1.9
This system’s lateral resolution is defined by the tight illumina-
tion focus, with relatively loosely focused ultrasonic detection.
The illumination light beam provided by a nanosecond-pulsed
laser is focused through an optical lens and reflected off an alu-
minum-coated prism assembly, which reflects light but transmits
sound, before striking the sample. The ultrasonic waves are
focused by a 0.5 NA plano-concave acoustic lens and detected
by a 50-MHz ultrasonic transducer (V214 BC, Olympus NDT).
The signal is then amplified, digitized, and transferred to a
computer. The whole imaging head—composed of the prism
assembly, ultrasound transducer, and mounting frame—is
raster-scanned to produce a 3-D image. The system scans
with a voice-coil scanner in the x-direction, and with a stepper
motor in the y-direction. A concurrent photodiode-reading
compensates for fluctuations in the laser-pulse energy. The
system resolution in the lateral direction is about 3.4 μm,
while the axial resolution is calculated to be around 15 μm.
While there are many diabetes mouse models, the streptozo-
tocin (STZ, Sigma) mouse model was chosen since it is indu-
cible and inexpensive. STZ is specifically toxic to the beta cells
of the pancreas, reducing the amount of insulin available to the
animal; its administration is an established method for inducing
insulin-dependent (type 1) diabetes in mice.10 PAT is particularly
well-suited for measuring changes in diabetic vasculature
because it can monitor vessel-by-vessel changes in diameter,
sO2, blood flow speed, and total hemoglobin concentrations.
In this study, eight ten-week old male ND4 Swiss Webster
mice, weighing approximately 30 g, were subjected to five con-
secutive intraperitoneal injections of an STZ solution. The injec-
tion concentration of 50mg∕kg in pH 4.5 citric buffer solution
was sufficient to produce diabetes in the mice. The mice were
subjected to food restriction for at least 6 h before injection.
Using the OR-PAM system, each mouse was imaged around
an artery and vein pair in the left ear. To monitor changes in
total hemoglobin concentration and vessel diameter, the hemo-
globin isosbestic point of 532 nm was used. To calculate the
sO2, 532 and 561 nm wavelengths were used. Finally, each
mouse was imaged for flow information with the method
described previously.11 Blood glucose was monitored using a
glucometer (FreeStyle Lite®). Before administration of STZ,
baseline measurements were acquired for all of the parameters.
After administration of STZ, blood glucose and body weight
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weeks to measure changes in vessel diameter, sO2, total hemo-
globin, and blood flow speed. Within three weeks of adminis-
tration of STZ, most mice developed a very significant rise in
blood glucose level (from an average around 100mg∕dL to just
under 400mg∕dL), which was indicative of severe uncontrolled
diabetes.12 Some representative results are shown in Fig. 2, with
(a) showing the changes in the diameters of both the vein and
artery in grayscale, along with the representative signal from the
vessels, which is proportional to total hemoglobin concentra-
tion. Figure 2(b) shows the sO2 calculated using a least-squares
fitting method.13 The green dashed line in (a) represents the
cross-section along which the flow measurements shown in
Fig. 2(c) were taken. The flow results in Fig. 2(c) show a clear
decrease in arterial flow speed and an increase in venous flow
speed, as well as a clear decrease in vein diameter. Figure 2 is
a representative data set of the mice tested. Four of the mice
succumbed to complications from diabetes before the six weeks
concluded.
The results for all the mice are summarized in Fig. 3, which
shows a variety of effects stemming from the developing dia-
betes. Much literature on human and animal studies details the
expected effects in the development of diabetes. Basically
there is a balance between disturbance due to high glucose levels
and the mouse’s natural compensatory response to the adverse
effects. As the blood glucose rose in the experimental mice
[Fig. 3(a)], vessel diameter decreased in the arteries and more
significantly in the veins [Fig. 3(b)], which can be explained
by compensation for volume loss due to polyurea. In diabetic
polyurea, high blood glucose leaks into the urine and causes
osmotic diuresis. Polyurea is responsible for the initial weight
loss in the mice shown in Fig. 3(c).12 The perfusion shown in
Fig. 3(d) was considered to be the percentage of area filled
with vessels in the imaged region excluding the main trunk ves-
sels. This parameter was measured to test for changes induced
initially by dehydration and subsequently by damage to the vessel
walls by mechanisms still not well understood but related to
the high blood glucose. However no significant change was
observed.12,14 As Fig. 3(e) and 3(f) shows, there was no signifi-
cant change in the sO2 level in either the artery or the vein
through the weeks, and there was also no significant change
in the total hemoglobin concentration. The total hemoglobin
concentration was calculated as the average signal from the artery
and vein at an isosbestic wavelength; the concentration of hemo-
globin at baseline was assumed to be 146 g∕L on the basis of
previous work.6
Presumably the metabolic demands of the mouse tissues
remained at a similar level, at least at the onset of the disease.
To compensate for the decreased vessel diameters, while still
maintaining the same flux of oxygen and nutrients, blood
flow speed must change correspondingly to maintain the volu-
metric flow rate. This trend is apparent in the results shown in
Fig. 3(g). The oxygen delivered to the tissue can be estimated
from blood flow, vessel diameter, and the oxygen extraction
fraction (OEF). This fraction, shown in Fig. 3(h), is calculated
to be the sO2 in the artery minus the sO2 in the vein, and the
result is divided by the sO2 in the artery. The O2 consumption
rate, shown in Fig. 3(i), takes into account the OEF, total hemo-
globin concentration, and the flow rate; this parameter is calcu-
lated as discussed previously.6 The flow rates in the artery-vein
pairs measured were the same within error at each of the weeks
measured. In the mice measured, the calculated O2 consumption
rate in the measured tissue region did not significantly change
through the weeks. The statistical analysis used was a one-way
unbalanced ANOVAwith a Tukey’s multiple comparison test. In
Fig. 3, the significance denoted for each week is in comparison
to the baseline of each mouse.
These results show the feasibility of using PAM to monitor
vascular changes associated with the sudden onset of
Fig. 1 System diagram for the optical-resolution photoacoustic
microscope.
Fig. 2 Representative results for one streptozotocin-induced diabetic mouse showing (a) structural photoacoustic maximum amplitude projections
(MAPs) through six weeks, (b) sO2 MAPs of oxygen saturation in the main artery-vein pair studied, and (c) fitted flow speed profile through a
cross section (green-dashed lines in panel a) of the main artery-vein pair. A: artery, V: vein.
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insulin-dependent diabetes in an STZ mouse model. There are
noticeable and measurable changes associated with the disease,
including decreased vessel diameter and possible occlusion due
to vessel damage and polyurea. We also measured compensatory
effects to maintain flow rate, and therefore nutrient delivery to
the tissues, in the form of changes in the blood flow speed in the
vessels, namely an increase in the flow speed in the vein and
a decrease in the artery. Functional and metabolic parameters
such as sO2, OEF, and O2 consumption were also successfully
measured, but showed no significant change. This study focused
on the vascular and metabolic changes in acute onset severe
uncontrolled insulin-dependent diabetes and clearly show mor-
phological changes in the vasculature in the short-term period
studied. Future studies will look into the long-term vascular
changes in inducible models of noninsulin-dependent diabetes
that would also improve animal survivability, as well as how
treatment can affect the outcomes.
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Fig. 3 Structural and functional changes from eight diabetic mice monitored for six weeks: (a) blood glucose concentration in mg∕dl, (b) artery and vein
diameters in mm, (c) mouse weight in grams, (d) perfusion in percent area, (e) sO2, (f) total hemoglobin concentration (HbT) in g∕L, (g) flow speed in
mm∕s, (h) oxygen extraction fraction, and (i) oxygen consumption rate in μl∕min. p < 0.05, n ¼ 8. Data are presented as means s:e.m.
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